- Carboplatin and paclitaxel as an initial treatment in patients with stage IVb cervical cancer: a report of 7 cases and a review of the literature
-
Mabuchi S, Morishige , Enomoto T, Kimura T
- KMID: 2009577
- J Gynecol Oncol.
- 2010 Jun;21(2):93-96.
- doi: 10.3802/jgo.2010.21.2.93
OBJECTIVE: The aim of this study is to evaluate the efficacy of carboplatin-paclitaxel (TC) as an initial treatment in patients with the International Federation of Gynecology and Obstetrics (FIGO) stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
-
Mabuchi S, Sugiyama T, Kimura T
- KMID: 2363325
- J Gynecol Oncol.
- 2016 May;27(3):e31.
- doi: 10.3802/jgo.2016.27.e31
Clear cell carcinoma (CCC) of the ovary is known to show poorer sensitivity to chemotherapeutic agents and to be associated with a worse prognosis than the more common serous adenocarcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic significance of tumor laterality in advanced ovarian cancer
-
Yamada Y, Mabuchi S, Kawahara N, Kawaguchi R
- KMID: 2522476
- Obstet Gynecol Sci.
- 2021 Nov;64(6):524-531.
- doi: 10.5468/ogs.21176
Objective This study aimed to investigate the effect of incorporating tumor laterality into the International Federation of Gynecology and Obstetrics (FIGO) staging system for advanced ovarian cancer. Methods The clinical data of 131... -
- CITED
-
- Close
- SHARE
-
- Close
- Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice
-
Shimura K, Mabuchi S, Yokoi T, Sasano T, Sawada K, Hamasaki T, Kimura T
- KMID: 2177873
- J Gynecol Oncol.
- 2013 Oct;24(4):321-329.
- doi: 10.3802/jgo.2013.24.4.321
OBJECTIVE: To investigate the utility of serum squamous cell carcinoma antigen (SCC-Ag) levels upon the diagnosis of recurrent cervical cancer for decision making in patient management. METHODS: Clinical records from 167... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma
-
Yokoi E, Mabuchi S, Takahashi , Matsumoto , Kuroda H, Kozasa K, Kimura T
- KMID: 2413458
- J Gynecol Oncol.
- 2017 Mar;28(2):e19.
- doi: 10.3802/jgo.2017.28.e19
OBJECTIVE: To compare the survival outcomes of patients with cervical squamous cell carcinoma (SCC) and adenocarcinoma/adenosquamous carcinoma (AC/ASC) among patients with locally advanced cervical cancer that were treated with definitive... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors
-
Matsuo K, Mabuchi S, Okazawa M, Kawano M, Kuroda H, Kamiura S, Kimura T
- KMID: 2158796
- J Gynecol Oncol.
- 2015 Jan;26(1):3-11.
- doi: 10.3802/jgo.2015.26.1.3
OBJECTIVE: Presence of high-risk factor in cervical cancer is known to be associated with decreased survival outcomes. However, the significance of multiple high-risk factors in early-stage cervical cancer related to... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients
-
Mabuchi S, Isohashi F, Okazawa M, Kitada F, Maruoka S, Ogawa K, Kimura T
- KMID: 2413856
- J Gynecol Oncol.
- 2017 Jan;28(1):e15.
- doi: 10.3802/jgo.2017.28.e15
OBJECTIVE: To evaluate the efficacy and toxicity of paclitaxel plus carboplatin (TC)-based concurrent chemoradiotherapy (CCRT) followed by consolidation chemotherapy in the International Federation of Gynecology and Obstetrics (FIGO) stage IIIB/IVA... -
- CITED
-
- Close
- SHARE
-
- Close
